Showing results (101-110 of 178) with videos related to

Sort By:
Pageof 18
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 20, 2019
Advances of immune checkpoints in colorectal cancer treatmentQinlian Jiao, Yidan Ren, Abakundana Nsenga Ariston Gabrie, et al.
Oncotarget|March 5, 2016
Long non-coding RNAs as prognostic markers in human breast cancerHairong Liu, Juan Li, Pratirodh Koirala, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|November 30, 2019
Differences between KC and KPC pancreatic ductal adenocarcinoma mice models, in terms of their modeling biology and their clinical relevanceAbakundana Nsenga Ariston Gabriel, Qinlian Jiao, Umwali Yvette, et al.
Oncology Letters|March 21, 2020
Expression levels and associations of five long non-coding RNAs in gastric cancer and their clinical significanceHelen Barong Binang, Yun-Shan Wang, Marlvin Anemey Tewara, et al.
Frontiers in Cell and Developmental Biology|November 12, 2020
LncRNA AC010789.1 Promotes Colorectal Cancer Progression by Targeting MicroRNA-432-3p/ZEB1 Axis and the Wnt/β-Catenin Signaling PathwayWeili Duan, Xue Kong, Juan Li, et al.
Cancer Management and Research|October 29, 2020
Evaluation of Serum Exosomal lncRNAs as Diagnostic and Prognostic Biomarkers for Esophageal Squamous Cell CarcinomaSuzhen Yan, Lutao Du, Xiumei Jiang, et al.
Medicine|December 31, 2015
Comparison of HE4, CA125, and ROMA Diagnostic Accuracy: A Prospective and Multicenter Study for Chinese Women With Epithelial Ovarian CancerPengjun Zhang, Chuanxin Wang, Liming Cheng, et al.
Oncotargets and Therapy|July 20, 2018
Increased expression of antisense lncRNA SPINT1-AS1 predicts a poor prognosis in colorectal cancer and is negatively correlated with its sense transcriptChen Li, Wei Li, Yanli Zhang, et al.
Biology Direct|August 17, 2023
Circular RNA hsa_circ_0067842 facilitates tumor metastasis and immune escape in breast cancer through HuR/CMTM6/PD-L1 axisJuan Li, Xiangjun Dong, Xue Kong, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 10, 2015
Development of a multi-marker model combining HE4, CA125, progesterone, and estradiol for distinguishing benign from malignant pelvic masses in postmenopausal womenPengjun Zhang, Chuanxin Wang, Liming Cheng, et al.
Pageof 18